Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT06702280 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Assessing the Safety of an IGY Supplement on the Gut Microbiome

StatusWithdrawn
PhasePhase 1/2
Started
View on ClinicalTrials.gov ↗

Record History

See every version on ClinicalTrials.gov ↗

  1. Withdrawn before enrolling Sponsor's reason: Sponsor cancelation Show 10 more changesShow less
    • Primary completion pushed from Oct 2025 to Oct 2026
    • Phase changed: Phase 1 → Phase 1/2
    • Enrollment target: estimated 20 to confirmed 0
    • Start date: Feb 2025 to Jan 2026
    • Study completion pushed from Oct 2025 to Oct 2027
    • Interventions modified
    • Trial arms changed: 1 → 2
    • Eligibility criteria expanded, about 24 words
    • Site contact updated
    • Collaborators shortened, about 7 words
  2. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
This study is to evaluate whether Muno-IgY is effective in enhancing immune health among adults over a six week period.
Trial Details
NCT Number NCT06702280
Lead Sponsor Nimble Science Ltd.
Conditions
(from sponsor)		 Healthy, Microbiome
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov